Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer

NCT03607188 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Alkotinib

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd